Webinar
7 Feb 2023

Solving the Pre-Filled Syringes Mystery for Low Temperature Applications (-80°C)

New therapeutic treatments or prophylactic vaccines rely on more complicated drug formulations, often based on biologics. These drugs are highly sensitive and might require low temperature storage to keep them stable over shelf life. These extreme cold supply chain processes, something up to -80°C, provide a new challenge to pre-fillable syringes. In this presentation we will show you scientifically based argumentations and results to help you to select the right pre-fillable syringe for your low temperature application.

Content provided by our supplier

SCHOTT Pharma AG & Co KGaA

  • DE
  • 2015
    On CPHI since
  • 1
    Certificates
  • 5000+
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Packaging materials

Other Content from SCHOTT Pharma AG & Co KGaA (14)

  • News Pharma supply chain companies form alliance to accelerate sustainability

    Alliance to Zero aims to facilitate the transition of the pharma sector to reach net zero emissions target
  • Webinar Lightning Talk - Device Circularity

    Learnings and experiences with establishing Takeback and Recycling systems for medical devices will be presented during this session, with a focus on regulatory, logistical and technical challenges and how to overcome them. Frode will also zoom in on the value of recycling and how to use the learnings to shape a different future addressing the way we use our resources and creating business around recycling.
  • Webinar Lightning Talk - PPWR and Recycled Content, How are Regulators Incorporating New Technologies?

    The proposed PPWR will overhaul everything about the way packaging is designed and used in the EU and is likely to influence global policy for many years. With tight targets for inclusion of recycled content for all industries, including pharmaceutical packaging from 2030, the industry is looking for safe ways to recirculate materials into contact sensitive applications. Regulators are exploring ways to increase the amount of high quality mechanically recycled material available, but also at the role of chemical recycling in expanding opportunities for circularity. We will explore the current regulatory debate looking at how to incorporate this new technology into the legislative framework.
  • Video Lightning Talk - Biopolymers - The Key to Less Carbon?

    The presentation will highlight how we can use bio attributed polymers to reduce the carbon footprint without compromising product safety. With certified bio circular raw materials polymers can be produced to enable our customers to reduce their carbon footprint.
  • Webinar Opening Remarks

    We are all willing to have sustainable products for the future. The open question is: how do we get there? This sustainability conference will start with inspiring experiences from sustainable healthcare initiatives. Presentations the focus on potential pathways and drivers for decarbonization of drug containment and delivery systems. The program gets complemented by discussion of what blocks our ecosystem from transforming and how those barriers can be overcome.
  • Webinar Keynote Address

    Towards a circular economy within the healthcare sector: What are the challenges? There is a fast-increasing awareness regarding the high environmental impact of our healthcare sector and the consequences it has. There is an urgent need for collaborative initiatives to reduce the environmental impact of our current and future healthcare practices. One way to approach this is the application of Circular Economy Strategies on Medical devices. During my presentation I will present Examples of collaborative Circular Economy initiatives by Industry and Hospitals.
  • Webinar Partner Presentation - SCHOTT Pharma

    Let’s play it green: Realizing a decarbonized supply chain in parenteral drug administration Pharmaceutical companies are under significant pressure to address climate change and implement sustainable practices in their operations. They face the imperative of meeting commitments and stringent targets for scientific advancements and carbon reduction. A significant portion of emissions is generated throughout the drug manufacturing supply chain. This presentation presents the steps necessary for achieving a decarbonized supply chain for parenteral drug administration. Additionally, the presentation will highlight the constraints individual companies face in driving change and emphasize the role of cross-company initiatives, such as the Alliance to Zero, in creating synergies across the industry.
  • Webinar Sustainability: An Open Dialogue for a Brighter Future. Stronger Together!

    Meet industry sustainability experts in an informal setup for an open discussion on what matters the most for you as part of the Pharma industry. What are your current sustainability planning issues and how could you solve them? What could be your next steps and with whom do you need to collaborate to reach your sustainability goals? Representatives of BioPhorum, PSCI, Nelipak, and Informa will be available to guide you to: start setting up your sustainability strategy & focus areas get started with your action plans connect you with the right partners Through our community, purposeful partnerships and meaningful content, you will get ideas and support needed to put sustainability at the heart of your business.
  • Webinar EVERIC® freeze - A Glass Vial Optimized for Deep Cold Storage

    After years of investment in research & development, pharmaceutical companies have brought to the market a growing number of new therapies based on mRNA or viral vector technology, which require storage at freezing temperatures. Deep cold storage poses great challenges to the primary packaging container. This session will be dedicated to exploring the challenges and latest developments in ensuring the integrity and stability of pharmaceuticals drugs stored at deep cold temperatures. The attendees will have the chance to learn about the benefits of the latest SCHOTT Pharma innovation: EVERIC® freeze, a glass vial, with optimized strength for deep cold applications down to -80°C.
  • Webinar Primary Packaging Solutions for Deep Cold Storage

    After years of investment in R&D, pharmaceutical companies have brought to the market a growing number of new therapies based on mRNA or viral vector technology, which require storage at freezing temperatures. Deep cold storage poses great challenges to the primary packaging container. This session will be dedicated to exploring the challenges and latest developments in ensuring the integrity and stability of pharmaceuticals drugs stored at deep cold temperatures. The attendees will have the chance to learn about the benefits of two SCHOTT Pharma innovations: TOPPAC® freeze, a polymer syringe suitable for deep cold storage down to -100°C, and EVERIC® freeze, a glass vial, with optimized strength for deep cold applications down to -80°C.
  • Webinar Increasing Patient Safety Through Higher Product Quality with RTU Vials

    In this presentation, attendees will learn about the profound impact of pre-sterilized and pre-washed vials, commonly known as ready-to-use (RTU) vials, on enhancing patient safety. The speech emphasizes how RTU vials contribute to a reduction in contamination risks, thereby decreasing the potential for product recalls and ultimately infections. By eliminating the need for laborious process development, validation, and quality control, RTU vials streamline processes by implementing highly standardized and effective sterilization and washing procedures directly into the product. Thus, saving valuable time and resources for pharmaceutical companies. Based on case studies, the healthcare benefits of implementing RTU vials in various pharmaceutical operations will be illustrated. Attendees will gain insights into how this approach not only elevates product quality but also plays a pivotal role in upholding patient safety standards.
  • Webinar End to End Sterility Assurance for Next Level Risk Mitigation

    In this webinar, originally broadcast as part of the Pharmapack Europe show, Dr. Robert Lindner, Global Product Manager RTU Vials, SCHOTT AG will discuss how sterile integrity is indispensable in aseptic fill-and-finish operations. Pharmaceutical companies pay highest attention to producing high quality drugs and safekeeping their efficacy during fill-and-Finish and beyond. The risks of contaminated batches leads to recalls, high costs, reputation loss and in the worst scenario may harm patients’ wellbeing. Hence, it is the pharma company’s obligation to ensure the sterility of all components when entering the aseptic filling core - which is possible, yet cumbersome with the RTU solutions that are currently available within the industry.